{"altmetric_id":230719,"counts":{"readers":{"mendeley":10,"citeulike":1,"connotea":0},"blogs":{"unique_users_count":1,"unique_users":[1192],"posts_count":1},"total":{"posts_count":2},"f1000":{"unique_users_count":1,"unique_users":["F1000Prime"],"posts_count":1}},"citation":{"abstract":"As a potential disease-modifying treatment for Alzheimer disease (AD), 3-amino-1-propanesulfonic acid (3APS) is a compound that binds to amyloid beta (Abeta), a toxic protein known to aggregate, leading to amyloid plaque deposition in the brain.","abstract_source":"pubmed","altmetric_jid":"4f6fa5ea3cf058f610005b59","authors":["P. S. Aisen","D. Saumier","R. Briand","J. Laurin","F. Gervais","P. Tremblay","D. Garceau"],"doi":"10.1212\/01.wnl.0000244346.08950.64","first_seen_on":"2011-08-16T05:03:59+00:00","issns":["1526-632X","0028-3878"],"issue":"10","journal":"Neurology","last_mentioned_on":1239417639,"links":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17082468","http:\/\/dx.doi.org\/10.1212\/01.wnl.0000244346.08950.64"],"pmid":"17082468","pubdate":"2006-11-28T00:00:00+00:00","publisher_subjects":[{"name":"Clinical Sciences","scheme":"era"},{"name":"Neurosciences","scheme":"era"},{"name":"Cognitive Science","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"subjects":["neurology"],"title":"A Phase II study targeting amyloid-\u03b2 with 3APS in mild-to-moderate Alzheimer disease","type":"article","volume":"67","mendeley_url":"http:\/\/www.mendeley.com\/research\/phase-ii-study-targeting-amyloid%CE%B2-3aps-mildtomoderate-alzheimer-disease"},"altmetric_score":{"score":9.672,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":9.672},"context_for_score":{"all":{"total_number_of_other_articles":3633617,"mean":4.9215564192856,"rank":307470,"this_scored_higher_than_pct":91,"this_scored_higher_than":3326152,"rank_type":"exact","sample_size":3633617,"percentile":91},"similar_age_3m":{"total_number_of_other_articles":51748,"mean":4.6649765976771,"rank":5288,"this_scored_higher_than_pct":89,"this_scored_higher_than":46460,"rank_type":"exact","sample_size":51748,"percentile":89},"this_journal":{"total_number_of_other_articles":5948,"mean":7.6084856230032,"rank":746,"this_scored_higher_than_pct":87,"this_scored_higher_than":5202,"rank_type":"exact","sample_size":5948,"percentile":87},"similar_age_this_journal_3m":{"total_number_of_other_articles":213,"mean":2.6584528301887,"rank":13,"this_scored_higher_than_pct":93,"this_scored_higher_than":200,"rank_type":"exact","sample_size":213,"percentile":93}}},"demographics":{"users":{"mendeley":{"by_status":{"Student  > Doctoral Student":2,"Researcher":1,"Student  > Ph. D. Student":1,"Student  > Master":2,"Other":2,"Student  > Bachelor":1,"Lecturer > Senior Lecturer":1},"by_discipline":{"Medicine and Dentistry":3,"Chemistry":3,"Agricultural and Biological Sciences":3,"Pharmacology, Toxicology and Pharmaceutical Science":1}}},"geo":{"mendeley":{"MY":1}}},"posts":{"blogs":[{"title":"Vivimind: Forget About It","url":"http:\/\/sciencebasedpharmacy.wordpress.com\/2009\/04\/10\/vivimind","license":"public","citation_ids":[230719,1379448],"posted_on":"2009-04-11T02:40:39+00:00","summary":"You\u2019ve seen the billboards for Vivimind across Canada. Remember them?\u00a0 Targeting an aging population of boomers, Vivimind is touted as a \u201cscientifically proven\u201d natural health product that \u201cprotects memory function\u201d. The website goes to great lengths to pr","author":{"name":"Science-Based Pharmacy","url":"http:\/\/sciencebasedpharmacy.wordpress.com\/","description":"Turning an eye on the profession, separating fact from fiction on both sides of the counter"}}],"f1000":[{"title":"Recommended in F1000 Prime","url":"https:\/\/f1000.com\/prime\/1053917","license":"public","citation_ids":[230719],"posted_on":"2007-02-07T00:00:00+00:00","f1000_classes":[],"f1000_score":"2"}]}}